Raymond T. Keane's most recent trade in Cullinan Oncology Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 22,500 | 24,124 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 249,998 | 249,998 | - | - | Stock Option (Right to Buy) |